3-(Trifluoromethyl)phenyl 6-(1H-1,2,4-triazol-1-yl)pyridine-3-carboxylate

Catalog No. :
ACBBJR182
CAS No. :
400079-25-6
Molecular Formula :
C15H9F3N4O2
Molecular Weight :
334.26

IUPAC Name:3-(trifluoromethyl)phenyl 6-(1H-1,2,4-triazol-1-yl)nicotinate

3-(Trifluoromethyl)phenyl 6-(1H-1,2,4-triazol-1-yl)pyridine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Trifluoromethyl)phenyl 6-(1H-1,2,4-triazol-1-yl)pyridine-3-carboxylate
IUPAC Name3-(trifluoromethyl)phenyl 6-(1H-1,2,4-triazol-1-yl)nicotinate
MDL No.MFCD00665552
Molecular FormulaC15H9F3N4O2
Molecular Weight334.26
SMILESO=C(C1=CC=C(N2N=CN=C2)N=C1)OC3=CC=CC(C(F)(F)F)=C3
InChI KeyNVYUPMXHRKXICJ-UHFFFAOYSA-N
Synonym3-(trifluoromethyl)phenyl 6-(1H-1,2,4-triazol-1-yl)pyridine-3-carboxylate;3-Pyridinecarboxylic acid, 6-(1H-1,2,4-triazol-1-yl)-, 3-(trifluoromethyl)phenyl ester
CAS No.400079-25-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBBJR182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQGXF328 route compound structure diagram
    ACQGXF328281232-20-0 In Stock
  2. Plus
  3. ACIVXL587 route compound structure diagram
    ACIVXL58798-17-9 In Stock
  4. Then
  5. ACBBJR182 route product structure diagram
    ACBBJR182400079-25-6
Inquiry

2. ACBBJR182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIVXL587 route compound structure diagram
    ACIVXL58798-17-9 In Stock
  4. Then
  5. ACBBJR182 route product structure diagram
    ACBBJR182400079-25-6
Inquiry

Comments (0)